The following report was written by Rema Nagarajan and was published by The Times of India on April 12, 2021.
This article summarizes a presentation made to India’s National Adverse Event Following Immunisation (AEFI) Committee last March 31, 2021. It showed that of the 180 deaths that occurred after immunization, 75% happened within three (3) days of the shot. The report also showed the same three-day window for other serious adverse events.
As the Indian Covishield is the same as AstraZeneca, health authorities also monitored for the conditions flagged by the European Medicines Agency (EMA) [learn more EMA confirms: AstraZeneca vaccine linked to rare blood clots]. As of the time of writing, 86 such events were recorded, with 18 resulting in death.
Editor’s Note: This report is important because it shows us that particularly for AstraZeneca, monitoring of adverse effects should go beyond 15 minutes after inoculation. Are vaccine recipients told to self-monitor for a few days? Are they given information on where to send reports of adverse reactions? Do vaccine recipients know what conditions they should be monitoring for?
Click the button below if you wish to read the article on the website where it was originally published.
Click the button below if you wish to read the article offline.